Yushak M - Search Results

1

Lymphocyte G proteins reflect response to treatment in congestive heart failure.

Horn EM, Kukin ML, Neuberg GW, Goldsmith RL, McCarty M, Gratch M, Medina N, Yushak M, Packer M, Bilezikian JP. Horn EM, et al. Among authors: yushak m. Am Heart J. 1995 Jan;129(1):98-106. doi: 10.1016/0002-8703(95)90049-7. Am Heart J. 1995. PMID: 7817932 Free article.

2

Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure.

Neuberg GW, Kukin ML, Penn J, Medina N, Yushak M, Packer M. Neuberg GW, et al. Among authors: yushak m. Am J Cardiol. 1991 Jan 1;67(1):63-6. doi: 10.1016/0002-9149(91)90101-p. Am J Cardiol. 1991. PMID: 1986506 Clinical Trial.

3

Cumulative hemodynamic response to short-term treatment with flosequinan (BTS 49465), a new direct-acting vasodilator drug, in severe chronic congestive heart failure.

Kessler PD, Packer M, Medina N, Yushak M. Kessler PD, et al. Among authors: yushak m. J Cardiovasc Pharmacol. 1988 Jul;12(1):6-11. doi: 10.1097/00005344-198807000-00002. J Cardiovasc Pharmacol. 1988. PMID: 2459536

4

Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.

Packer M, Medina N, Yushak M. Packer M, et al. Among authors: yushak m. Am Heart J. 1982 Nov;104(5 Pt 2):1215-23. doi: 10.1016/0002-8703(82)90054-0. Am Heart J. 1982. PMID: 6753552

5

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD, et al. Krum H, et al. Among authors: yushak m. Circulation. 1995 Sep 15;92(6):1499-506. doi: 10.1161/01.cir.92.6.1499. Circulation. 1995. PMID: 7664433 Clinical Trial.

6

Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure.

Krum H, Gu A, Wilshire-Clement M, Sackner-Bernstein J, Goldsmith R, Medina N, Yushak M, Miller M, Packer M. Krum H, et al. Among authors: yushak m. Am Heart J. 1996 Feb;131(2):337-41. doi: 10.1016/s0002-8703(96)90363-4. Am Heart J. 1996. PMID: 8579030 Free article. Clinical Trial.

7

Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.

Gottlieb SS, Kukin ML, Medina N, Yushak M, Packer M. Gottlieb SS, et al. Among authors: yushak m. Circulation. 1990 Mar;81(3):860-4. doi: 10.1161/01.cir.81.3.860. Circulation. 1990. PMID: 2106401 Clinical Trial.

8

Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure.

Gottlieb SS, Kukin ML, Yushak M, Medina N, Packer M. Gottlieb SS, et al. Among authors: yushak m. Ann Intern Med. 1989 Apr 1;110(7):505-9. doi: 10.7326/0003-4819-110-7-505. Ann Intern Med. 1989. PMID: 2493762

9

Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.

Packer M, Lee WH, Kessler PD, Medina N, Yushak M, Gottlieb SS. Packer M, et al. Among authors: yushak m. J Am Coll Cardiol. 1987 Oct;10(4):837-44. doi: 10.1016/s0735-1097(87)80278-4. J Am Coll Cardiol. 1987. PMID: 2821091 Free article.

10

Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.

Packer M, Medina N, Yushak M. Packer M, et al. Among authors: yushak m. J Am Coll Cardiol. 1986 Mar;7(3):671-80. doi: 10.1016/s0735-1097(86)80479-x. J Am Coll Cardiol. 1986. PMID: 2869077 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters